vTv Therapeutics (VTVT) Short Interest Ratio & Short Volume $19.74 +0.93 (+4.91%) As of 04/17/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock vTv Therapeutics Short Interest DatavTv Therapeutics (VTVT) has a short interest of 16,100 shares, representing 1.09% of the float (the number of shares available for trading by the public). This marks a -34.29% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 23,023 shares to cover all short positions.Current Short Interest16,100 sharesPrevious Short Interest24,500 sharesChange Vs. Previous Month-34.29%Dollar Volume Sold Short$278,852.00Short Interest Ratio0.7 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares3,190,000 sharesFloat Size1,480,000 sharesShort Percent of Float1.09%Today's Trading Volume15,172 sharesAverage Trading Volume23,023 sharesToday's Volume Vs. Average66% Short Selling vTv Therapeutics? Sign up to receive the latest short interest report for vTv Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVTVT Short Interest Over TimeVTVT Days to Cover Over TimeVTVT Percentage of Float Shorted Over Time vTv Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202516,100 shares $278,852.00 -34.3%1.1%0.7 $17.32 3/15/202524,500 shares $363,825.00 +1.7%1.7%1.1 $14.85 2/28/202524,100 shares $473,806.00 -13.6%1.6%1.8 $19.66 2/15/202527,900 shares $605,430.00 +4.5%1.9%1.8 $21.70 1/31/202526,700 shares $417,054.00 +18.7%1.8%1.1 $15.62 1/15/202522,500 shares $316,125.00 +33.1%1.5%0.8 $14.05 12/31/202416,900 shares $233,389.00 No Change1.1%0.6 $13.81 12/15/202416,900 shares $254,007.00 -24.9%1.1%0.6 $15.03 11/30/202422,500 shares $360,900.00 -17.3%1.6%0.7 $16.04 11/15/202427,200 shares $469,200.00 -5.9%1.9%0.9 $17.25 Get the Latest News and Ratings for VTVT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for vTv Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/202428,900 shares $396,508.00 -0.3%2.2%1 $13.72 10/15/202429,000 shares $386,860.00 -7.9%2.3%1 $13.34 9/30/202431,500 shares $424,620.00 +1.6%2.4%1.1 $13.48 9/15/202431,000 shares $442,060.00 -6.3%2.4%1 $14.26 8/31/202433,100 shares $520,001.00 -13.1%2.6%1.2 $15.71 8/15/202438,100 shares $513,969.00 +34.6%3.0%1.5 $13.49 7/31/202428,300 shares $429,028.00 +45.9%2.2%1.4 $15.16 7/15/202419,400 shares $473,166.00 -1.0%1.5%1.6 $24.39 6/30/202419,600 shares $346,136.00 -10.5%1.5%2.6 $17.66 6/15/202421,900 shares $460,338.00 +17.7%1.7%3.4 $21.02 5/31/202418,600 shares $433,938.00 -21.9%1.4%1.8 $23.33 5/15/202423,800 shares $615,944.00 -10.5%1.8%0.4 $25.88 4/30/202426,600 shares $742,140.00 -7.6%3.2%0.4 $27.90 4/15/202428,800 shares $720,000.00 -10.6%3.4%0.4 $25.00 3/31/202432,200 shares $757,666.00 -43.7%6.1%0.4 $23.53 3/15/202457,200 shares $1.03 million +50.5%10.9%0.8 $18.00 2/29/202438,000 shares $666,900.00 -12.0%8.4%0.5 $17.55 2/15/202443,200 shares $415,152.00 -39.1%6.5%1.4 $9.61 1/31/202470,900 shares $596,269.00 +78.6%10.7%2.2 $8.41 1/15/202439,700 shares $363,255.00 -20.8%6.0%1.5 $9.15 12/31/202350,100 shares $576,150.00 +27.8%N/A2.3 $11.50 12/15/202339,200 shares $343,000.00 +10.4%5.9%2 $8.75 11/30/202335,500 shares $507,295.00 +25.0%5.3%2.1 $14.29 11/15/202328,400 shares $398,736.00 -97.6%4.3%7.7 $14.04 10/31/20231,180,000 shares $484,980.00 -6.4%4.4%7.1 $0.41 10/15/20231,260,000 shares $587,286.00 +4.1%4.7%7.1 $0.47 9/30/20231,210,000 shares $578,380.00 -4.0%4.5%6.7 $0.48 9/15/20231,260,000 shares $560,826.00 +4.1%4.6%7.6 $0.45 8/31/20231,210,000 shares $617,100.00 -13.6%4.4%5.8 $0.51 8/15/20231,400,000 shares $998,760.00 +15.7%5.1%6.2 $0.71The U.S. just rewrote the rules of retirement (Ad)For decades, Wall Street told retirees to stick with big names, stay diversified, and live off dividends. But Tim Plaehn says those rules no longer apply — and the 2025 trade war is exposing just how fragile that plan really was. Tim just released a video briefing explaining how the global shift is hammering traditional income stocks — and how a few U.S.-focused companies are built to weather the chaos.Watch the 2025 Trade War dividend protection briefing now 7/31/20231,210,000 shares $817,960.00 -4.7%4.4%8.5 $0.68 7/15/20231,270,000 shares $915,670.00 -1.6%4.6%9.8 $0.72 6/30/20231,290,000 shares $954,342.00 +7.5%4.7%10.2 $0.74 6/15/20231,200,000 shares $911,880.00 -3.2%4.4%9.6 $0.76 5/31/20231,240,000 shares $979,600.00 +6.9%4.5%15.1 $0.79 5/15/20231,160,000 shares $996,208.00 -1.7%4.2%12.6 $0.86 4/30/20231,180,000 shares $908,600.00 -0.8%4.3%13.4 $0.77 4/15/20231,190,000 shares $880,838.00 -0.8%4.4%13.6 $0.74 3/31/20231,200,000 shares $969,360.00 -1.6%4.4%12.2 $0.81 3/15/20231,220,000 shares $964,044.00 +8.9%4.5%11.5 $0.79 2/28/20231,120,000 shares $907,200.00 No Change4.1%10.3 $0.81 2/15/20231,120,000 shares $985,600.00 -4.3%4.1%17.3 $0.88 1/31/20231,170,000 shares $1.11 million +3.5%4.3%16.6 $0.95 1/15/20231,130,000 shares $921,967.00 -4.2%4.1%16.4 $0.82 12/30/20221,180,000 shares $782,104.00 +8.3%4.3%17.9 $0.66 12/15/20221,090,000 shares $775,971.00 +2.8%4.0%18.1 $0.71 11/30/20221,060,000 shares $873,864.00 -1.9%3.9%15.5 $0.82 11/15/20221,080,000 shares $950,508.00 -3.6%4.0%15.2 $0.88 10/31/20221,120,000 shares $967,680.00 No Change4.1%10.2 $0.86 10/15/20221,120,000 shares $958,048.00 -8.2%4.1%6.3 $0.86 9/30/20221,220,000 shares $1.18 million -0.8%4.5%5.3 $0.97 9/15/20221,230,000 shares $1.41 million -3.2%4.5%5 $1.15 8/31/20221,270,000 shares $1.35 million -5.9%8.1%4.4 $1.06 8/15/20221,350,000 shares $1.85 million -19.2%6.1%1.5 $1.37 7/31/20221,670,000 shares $1.50 million +21.9%9.2%1.8 $0.90 7/15/20221,370,000 shares $934,340.00 -9.3%7.5%1.6 $0.68 6/30/20221,510,000 shares $1.13 million -15.2%8.3%1.8 $0.75 6/15/20221,780,000 shares $1.34 million +17.1%9.8%2.1 $0.76 5/31/20221,520,000 shares $837,520.00 -13.1%5.3%1.8 $0.55 5/15/20221,750,000 shares $743,750.00 No Change6.1%6.7 $0.43 4/30/20221,750,000 shares $1.21 million -0.6%6.1%7.5 $0.69 4/15/20221,760,000 shares $1.39 million +1.2%6.1%7.3 $0.79 3/31/20221,740,000 shares $1.26 million +3.6%6.1%6.9 $0.72 3/15/20221,680,000 shares $924,840.00 -13.0%5.9%5.7 $0.55 2/28/20221,930,000 shares $1.58 million +19.1%6.7%6.2 $0.82 2/15/20221,620,000 shares $1.20 million -0.6%5.7%5.1 $0.74 1/31/20221,630,000 shares $1.17 million +1.2%5.4%4.4 $0.72 1/15/20221,610,000 shares $1.42 million -5.3%5.3%3.5 $0.88 12/31/20211,700,000 shares $1.69 million -6.1%N/A2.8 $1.00 12/15/20211,810,000 shares $2.03 million -13.4%6.0%1.1 $1.12 11/30/20212,090,000 shares $2.59 million -2.3%8.0%1.1 $1.24 11/15/20212,140,000 shares $3.32 million +9.2%8.2%1.2 $1.55 10/29/20211,960,000 shares $2.80 million -22.8%8.4%1.1 $1.43 10/15/20212,540,000 shares $3.73 million +15.5%10.8%1.5 $1.47 9/30/20212,200,000 shares $3.37 million +39.2%9.4%1.4 $1.53 9/15/20211,580,000 shares $2.73 million -8.7%6.7%1.1 $1.73 8/31/20211,730,000 shares $3.24 million -14.4%7.4%1.6 $1.87 8/13/20212,020,000 shares $3.72 million -4.3%8.6%1.6 $1.84 7/30/20212,110,000 shares $4.05 million +2.9%9.0%1.4 $1.92 7/15/20212,050,000 shares $4.12 million -10.1%8.7%1.3 $2.01The U.S. just rewrote the rules of retirement (Ad)For decades, Wall Street told retirees to stick with big names, stay diversified, and live off dividends. But Tim Plaehn says those rules no longer apply — and the 2025 trade war is exposing just how fragile that plan really was. Tim just released a video briefing explaining how the global shift is hammering traditional income stocks — and how a few U.S.-focused companies are built to weather the chaos.Watch the 2025 Trade War dividend protection briefing now 6/30/20212,280,000 shares $5.20 million -5.4%10.3%0.4 $2.28 6/15/20212,410,000 shares $6.17 million +5.7%10.9%0.4 $2.56 5/28/20212,280,000 shares $5.61 million -11.3%10.7%0.4 $2.46 5/14/20212,570,000 shares $5.83 million -17.4%12.2%0.5 $2.27 4/30/20213,110,000 shares $8.21 million -39.9%14.8%0.5 $2.64 4/15/20215,170,000 shares $17.22 million +138.3%24.8%0.7 $3.33 3/31/20212,170,000 shares $5.82 million -4.4%10.4%0.7 $2.68 3/15/20212,270,000 shares $6.13 million -9.9%11.0%0.7 $2.70 2/26/20212,520,000 shares $6.40 million -17.7%15.9%0.5 $2.54 2/12/20213,060,000 shares $8.26 million -7.0%21.8%0.6 $2.70 1/29/20213,290,000 shares $6.58 million +12.3%25.4%0.7 $2.00 1/15/20212,930,000 shares $6.30 million +5.0%22.6%0.9 $2.15 12/31/20202,790,000 shares $5.38 million -26.8%21.5%1 $1.93 12/15/20203,810,000 shares $11.32 million +73.2%29.4%1.4 $2.97 11/30/20202,200,000 shares $4.73 million +5.3%18.2%3.4 $2.15 10/30/20201,940,000 shares $3.38 million -2.0%15.3%3.9 $1.74 10/15/20201,980,000 shares $3.45 million -1.0%16.5%4.2 $1.74 9/30/20202,000,000 shares $3.54 million +0.5%16.7%4.1 $1.77 9/15/20201,990,000 shares $3.88 million +4.7%16.6%3.8 $1.95 8/31/20201,900,000 shares $3.95 million +8.6%15.8%3.4 $2.08 8/14/20201,750,000 shares $4.25 million -0.6%18.7%2.9 $2.43 7/31/20201,760,000 shares $4.14 million -7.4%18.8%2.6 $2.35 7/15/20201,900,000 shares $4.45 million -9.5%21.8%4.4 $2.34 6/30/20202,100,000 shares $4.68 million +16.7%24.1%5.1 $2.23 6/15/20201,800,000 shares $4.99 million +0.6%20.6%4.8 $2.77 5/29/20201,790,000 shares $5.16 million +0.6%20.5%6.4 $2.88 5/15/20201,780,000 shares $5.30 million +5.3%20.4%5.5 $2.98 4/30/20201,690,000 shares $3.58 million +10.5%20.1%2.4 $2.12 VTVT Short Interest - Frequently Asked Questions What is vTv Therapeutics' current short interest? Short interest is the volume of vTv Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 16,100 shares of VTVT short. 1.09% of vTv Therapeutics' shares are currently sold short. Learn More on vTv Therapeutics' current short interest. What is a good short interest ratio for vTv Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VTVT shares currently have a short interest ratio of 1.0. Learn More on vTv Therapeutics's short interest ratio. What is a good short interest percentage for vTv Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.09% of vTv Therapeutics' floating shares are currently sold short. Is vTv Therapeutics' short interest increasing or decreasing? vTv Therapeutics saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 16,100 shares, a decrease of 34.3% from the previous total of 24,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is vTv Therapeutics' float size? vTv Therapeutics currently has issued a total of 3,190,000 shares. Some of vTv Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. vTv Therapeutics currently has a public float of 1,480,000 shares. How does vTv Therapeutics' short interest compare to its competitors? 1.09% of vTv Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to vTv Therapeutics: Candel Therapeutics, Inc. (12.93%), Aurora Cannabis Inc. (9.02%), Astria Therapeutics, Inc. (6.16%), Compass Therapeutics, Inc. (8.20%), Bright Minds Biosciences Inc. (2.03%), Monopar Therapeutics Inc. (1.32%), Nuvectis Pharma, Inc. (13.46%), Lifecore Biomedical, Inc. (7.91%), Y-mAbs Therapeutics, Inc. (10.62%), Acelyrin, Inc. (4.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short vTv Therapeutics stock? Short selling VTVT is an investing strategy that aims to generate trading profit from vTv Therapeutics as its price is falling. VTVT shares are trading up $0.88 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against vTv Therapeutics? A short squeeze for vTv Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VTVT, which in turn drives the price of the stock up even further. How often is vTv Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VTVT, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Candel Therapeutics Short Interest Aurora Cannabis Short Interest Astria Therapeutics Short Interest Compass Therapeutics Short Interest Bright Minds Biosciences Short Interest Monopar Therapeutics Short Interest Nuvectis Pharma Short Interest Lifecore Biomedical Short Interest Y-mAbs Therapeutics Short Interest Acelyrin Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VTVT) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VTVT Stock Free VTVT Stock Alerts